Market open
Profound Medical/$PROF
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Profound Medical
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Ticker
$PROF
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Mississauga, Canada
Employees
142
ISIN
CA74319B5027
Website
Profound Medical Metrics
BasicAdvanced
$135M
-
-$1.22
0.26
-
Price and volume
Market cap
$135M
Beta
0.26
52-week high
$11.42
52-week low
$3.90
Average daily volume
95K
Financial strength
Current ratio
11.315
Quick ratio
9.896
Long term debt to equity
9.1
Total debt to equity
9.614
Management effectiveness
Return on assets (TTM)
-38.43%
Return on equity (TTM)
-66.13%
Valuation
Price to revenue (TTM)
10.006
Price to book
3.7
Price to tangible book (TTM)
3.72
Price to free cash flow (TTM)
-4.363
Growth
Revenue change (TTM)
75.01%
Earnings per share change (TTM)
-4.84%
3-year revenue growth (CAGR)
16.38%
3-year earnings per share growth (CAGR)
-7.20%
What the Analysts think about Profound Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Profound Medical stock.
Profound Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Profound Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Profound Medical News
AllArticlesVideos
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
GlobeNewsWire·2 days ago
Profound Medical Corporation (PROF) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha·1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Profound Medical stock?
Profound Medical (PROF) has a market cap of $135M as of May 16, 2025.
What is the P/E ratio for Profound Medical stock?
The price to earnings (P/E) ratio for Profound Medical (PROF) stock is 0 as of May 16, 2025.
Does Profound Medical stock pay dividends?
No, Profound Medical (PROF) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Profound Medical dividend payment date?
Profound Medical (PROF) stock does not pay dividends to its shareholders.
What is the beta indicator for Profound Medical?
Profound Medical (PROF) has a beta rating of 0.26. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.